Medifast Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 30, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	99	181	655	1,173	2,131	1,881
Market Cap Growth	-37.48%	-72.34%	-44.11%	-44.98%	13.33%	66.56%
Enterprise Value	-37	34	533	1,133	2,008	1,752
Last Close Price	9.02	16.62	61.20	99.96	167.59	136.46
PE Ratio	468.19	89.76	7.29	8.73	14.78	22.37
PS Ratio	0.27	0.31	0.68	0.78	1.59	2.46
PB Ratio	0.54	0.89	3.60	8.08	11.97	14.63
P/TBV Ratio	0.54	0.89	3.60	8.08	11.97	14.63
P/FCF Ratio	179.74	11.03	5.13	7.05	40.17	16.52
P/OCF Ratio	16.14	7.67	4.91	6.44	25.64	15.85
EV/Sales Ratio	-	0.06	0.55	0.76	1.50	2.29
EV/EBITDA Ratio	-	1.26	4.22	6.19	10.24	15.48
EV/EBIT Ratio	-	2.30	4.66	6.55	10.56	15.97
EV/FCF Ratio	-66.77	2.08	4.17	6.81	37.85	15.38
Debt / Equity Ratio	0.06	0.08	0.11	0.17	0.16	0.07
Debt / EBITDA Ratio	0.48	0.49	0.15	0.13	0.14	0.08
Debt / FCF Ratio	18.98	0.95	0.16	0.15	0.54	0.08
Asset Turnover	1.54	2.03	3.42	4.47	4.53	3.97
Inventory Turnover	3.74	3.25	3.42	3.07	3.41	4.64
Quick Ratio	3.71	2.53	1.63	0.62	0.65	1.57
Current Ratio	4.45	3.34	2.43	1.58	1.81	2.10
Return on Equity (ROE)	0.12%	1.02%	55.77%	80.31%	91.20%	78.50%
Return on Assets (ROA)	1.52%	3.24%	25.24%	32.33%	40.08%	35.63%
Return on Invested Capital (ROIC)	1.40%	12.37%	116.95%	131.72%	274.89%	1044.12%
Return on Capital Employed (ROCE)	3.10%	7.00%	58.10%	105.40%	94.60%	81.40%
Earnings Yield	0.21%	1.11%	13.72%	11.46%	6.77%	4.47%
FCF Yield	0.56%	9.07%	19.49%	14.19%	2.49%	6.05%
Dividend Yield	-	-	7.32%	6.14%	2.98%	2.71%
Payout Ratio	78.63%	34.19%	73.45%	49.89%	38.93%	51.71%
Buyback Yield / Dilution	-0.27%	-0.39%	3.15%	4.55%	0.31%	2.20%
Total Shareholder Return	-0.27%	-0.39%	10.46%	10.69%	3.29%	4.91%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.